Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Operating Expenses | 0 | 26,945 | 25,883 | 26,316 | 0 |
| Operating Income | N/A | -26,945 | -25,883 | -26,316 | N/A |
| Other Income | 0 | 5,642 | 3,626 | 3,274 | 0 |
| Pre-tax Income | 0 | -21,303 | -22,257 | -23,042 | 0 |
| Net Income Continuous | N/A | -21,303 | -22,257 | -23,042 | N/A |
| Net Income | $N/A | $-21,303 | $-22,257 | $-23,042 | $N/A |
| EPS Basic Total Ops | N/A | -0.75 | -0.90 | -0.94 | N/A |
| EPS Basic Continuous Ops | N/A | -0.75 | -0.90 | -0.94 | N/A |
| EPS Diluted Total Ops | N/A | -0.75 | -0.90 | -0.94 | N/A |
| EPS Diluted Continuous Ops | N/A | -0.75 | -0.90 | -0.94 | N/A |
| EBITDA(a) | $N/A | $-25,525 | $-24,874 | $-26,316 | $N/A |